Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
14:15
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Clotting Factor Concentrates

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Activation of neutrophils by plasma derived FVIII concentrates  Martin Brodde 1      7/20/2016 10:44:00 PM  
Protein aggregates in plasma-derived factor IX (pdFIX) concentrates support platelet activation and microparticle formation in vitro.  Martin Brodde 1      7/20/2016 10:41:00 PM  
Improved pharmacokinetics and bleeding efficacy of recombinant Factor IX Fc-XTEN in hemophilia-B mice  Arjan van 1      7/19/2016 2:30:00 PM  
guardian5: a prospective non-interventional study of the treatment of severe and moderately severe haemophilia A with turoctocog alfa  Stephanie Gibbons 1      7/8/2016 6:39:00 PM  
The extent of VWF:Ag rise during moderate physical activity modulates FVIII half-life in severe haemophilia A subjects  Clemence Merlen 1      7/7/2016 7:56:00 PM  
Evolution of clotting factor consumption over the last fifteen years for ambulatory hemophilia patients in a French comprehensive care center  Florianne Bel 1      7/7/2016 7:30:00 PM  
Patients Classification with Hemophilia A by FVIII Cromogenic Assay  Mirta Arias 1      7/7/2016 5:43:00 PM  
Safety and efficacy of B-domain deleted 3rd generation recombinant factor VIII (GreenGene F) in Korean patients with haemophilia A: Data from a post-marketing surveillance study  Soon Ki Kim Soon Ki Kim 1      7/7/2016 12:15:00 PM  
Comparison of Different Prophylaxis Regimens for Moderate/severe Hemophilia A Children  Darintr Sosothikul 1      7/6/2016 6:54:00 AM  
Comparison of FXIII activity and antigen measurement during pregnancy  Carsten Detering 1      7/5/2016 1:13:00 PM  
Influence of Complement factor H on Factor XIIIA activation: a preliminary study  SNEHA GUPTA 1      7/5/2016 10:46:00 AM  
The effects of a long-acting factor IX product (N9-GP) on wound healing  Maureane Hoffman 1      7/4/2016 8:43:00 PM  
Variations of Factor XIII level during pregnancy  Gianluca Sottilotta 1      7/4/2016 4:55:00 PM  
A Novel Mutation in Child with Severe Congenital Factor X Deficiency  Davut Albayrak 1      7/3/2016 2:24:00 AM  
Severe Congenital factor V deficiency in the north region of Turkey  Canan Albayrak 1      7/3/2016 2:07:00 AM  
DNA methylation of Factor VIII secreting endothelial cells and several other endothelial cells in comparision to blood  Muhammad Ahmer 1      6/28/2016 2:56:00 PM  
In silico models for genotype/phenotype correlations of F9 gene mutations causing severe Hemophilia B  Lennon MelÚndez-Aranda 1      6/2/2016 7:34:00 PM  
       




Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 4
Visits: 50
Title: Activation of neutrophils by plasma derived FVIII concentrates
Authors: Martin Brodde ,
Centre: OxProtect.com


 






PosterSessionOnline
Logo Draft
 
Logo Cert